MARKET

AIMD

AIMD

Ainos Inc
NASDAQ
0.7501
+0.0001
+0.01%
Closed 16:00 01/27 EST
OPEN
0.7422
PREV CLOSE
0.7500
HIGH
0.8789
LOW
0.7422
VOLUME
4.84K
TURNOVER
912
52 WEEK HIGH
18.00
52 WEEK LOW
0.5539
MARKET CAP
15.01M
P/E (TTM)
-0.7293
1D
5D
1M
3M
1Y
5Y
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 4d ago
Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug
Benzinga · 5d ago
Ainos Issues 2023 Shareholder Letter
Benzinga · 01/17 12:04
BRIEF-Ainos Inc Receives Notice Of Delisting From Nasdaq
Reuters · 01/10 21:34
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Benzinga · 12/01/2022 18:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 12/01/2022 17:31
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 11/29/2022 17:31
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 11/29/2022 16:47
More
About AIMD
Ainos, Inc. is engaged in developing biologics for the treatment of human and animal diseases. The Company is researching for the treatment of human disease indications, including Sjogren’s syndrome, thrombocytopenia, and other indications using interferon-alpha. The Company is also developing and manufacturing point-of-care testing rapid test kit products that include diagnostics for COVID-19, pneumonia, vaginal infection and helicobacter pylori bacterial infection. Its business units include Pharmaceutical, Medical Devices and Preventive Medicine Divisions. Pharmaceutical Division is focused on low-dose, orally administered lozenges containing the natural immune system activator interferon-alpha as a treatment for a variety of disease indications. Medical Device Division is developing an insulin pump and further development of point-of-care rapid test kits for the detection and diagnosis of human infections. Preventative Medicine Division is focused on SRNA-based therapeutics.

Webull offers kinds of Ainos Inc stock information, including NASDAQ:AIMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AIMD stock methods without spending real money on the virtual paper trading platform.